BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34291700)

  • 1. Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview.
    Bergmann L; Weber S; Hartmann A; Ahrens M
    Expert Rev Anticancer Ther; 2021 Nov; 21(11):1273-1286. PubMed ID: 34291700
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.
    Koguchi T; Naito S; Hatakeyama S; Numakura K; Muto Y; Kato R; Kojima T; Kawasaki Y; Morozumi K; Kandori S; Kawamura S; Nishiyama H; Ito A; Habuchi T; Obara W; Ohyama C; Tsuchiya N; Kojima Y
    Cancer Med; 2023 Nov; 12(22):20677-20689. PubMed ID: 37905674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
    Wilson NR; Acikgoz Y; Hasanov E
    Int J Cancer; 2024 Mar; 154(6):947-961. PubMed ID: 37823185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.
    Zoumpourlis P; Genovese G; Tannir NM; Msaouel P
    Clin Genitourin Cancer; 2021 Apr; 19(2):103-116. PubMed ID: 33358151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
    Albiges L; Molinie V; Escudier B
    Oncologist; 2012; 17(8):1051-62. PubMed ID: 22807514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.
    Chahoud J; Msaouel P; Campbell MT; Bathala T; Xiao L; Gao J; Zurita AJ; Shah AY; Jonasch E; Sharma P; Tannir NM
    Oncologist; 2020 Mar; 25(3):252-258. PubMed ID: 32162795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options.
    Ahrens M; Scheich S; Hartmann A; Bergmann L;
    Oncol Res Treat; 2019; 42(3):128-135. PubMed ID: 30799404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches.
    Ornstein MC; Hutson TE
    Cancer J; 2020; 26(5):441-447. PubMed ID: 32947312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities.
    Zarrabi K; Walzer E; Zibelman M
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
    Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
    Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma.
    Osterman CK; Rose TL
    Kidney Cancer; 2020; 4(1):15-27. PubMed ID: 34435168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma.
    Bersanelli M; Rebuzzi SE; Roviello G; Catalano M; Brunelli M; Rizzo M
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171672. PubMed ID: 36758960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies.
    Ciccarese C; Iacovelli R; Brunelli M; Massari F; Bimbatti D; Fantinel E; De Marco V; Porcaro AB; Martignoni G; Artibani W; Tortora G
    Eur J Cancer; 2017 Sep; 83():237-246. PubMed ID: 28756136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immunotherapy in non-clear cell renal cell carcinoma.
    Climent C; Soriano S; Bonfill T; Lopez N; Rodriguez M; Sierra M; Andreu P; Fragio M; Busquets M; Carrasco A; Cano O; Seguí MA; Gallardo E
    Front Oncol; 2023; 13():941835. PubMed ID: 36816976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria.
    Kroeger N; Xie W; Lee JL; Bjarnason GA; Knox JJ; Mackenzie MJ; Wood L; Srinivas S; Vaishamayan UN; Rha SY; Pal SK; Yuasa T; Donskov F; Agarwal N; Kollmannsberger CK; Tan MH; North SA; Rini BI; Choueiri TK; Heng DY
    Cancer; 2013 Aug; 119(16):2999-3006. PubMed ID: 23696129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.
    Ciccarese C; Massari F; Santoni M; Heng DY; Sotte V; Brunelli M; Conti A; Cheng L; Lopez-Beltran A; Scarpelli M; Cascinu S; Tortora G; Montironi R
    Cancer Treat Rev; 2015 Jul; 41(7):614-22. PubMed ID: 26036356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
    John A; Spain L; Hamid AA
    Curr Oncol; 2023 Jan; 30(1):923-937. PubMed ID: 36661719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real World Data of Diagnosis, Survival, and Treatment Outcomes in Patients With Metastatic Non Clear Cell Renal Cell Carcinoma.
    Izarn F; Allignet B; Gille R; Boyle H; Neidhardt EM; Négrier S; Fléchon A
    Clin Genitourin Cancer; 2023 Apr; 21(2):e35-e43. PubMed ID: 36272959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022.
    Maughan BL
    Curr Oncol Rep; 2022 Sep; 24(9):1201-1208. PubMed ID: 35438388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.